These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2067211)

  • 1. Identification of a low molecular weight inhibitor of osteoblast mitogenesis in uremic plasma.
    Andress DL; Howard GA; Birnbaum RS
    Kidney Int; 1991 May; 39(5):942-5. PubMed ID: 2067211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatomedin inhibitor in uremia.
    Phillips LS; Fusco AC; Unterman TG; del Greco F
    J Clin Endocrinol Metab; 1984 Oct; 59(4):764-72. PubMed ID: 6384255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight peptides in bone extracts that stimulate osteoblast mitogenesis.
    Birnbaum RS; Andress DL
    Biochem Biophys Res Commun; 1990 Nov; 173(1):382-7. PubMed ID: 2256930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells.
    Perkel VS; Mohan S; Herring SJ; Baylink DJ; Linkhart TA
    Cancer Res; 1990 Nov; 50(21):6902-7. PubMed ID: 1698544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum.
    Bourgoignie J; Klahr S; Bricker NS
    J Clin Invest; 1971 Feb; 50(2):303-11. PubMed ID: 5540168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of IGF system component levels and mitogenic activity of uremic serum on normal human osteoblasts.
    Wagner MS; Stracke S; Jehle PM; Keller F; Zellner D; Baylink DJ; Mohan S
    Nephron; 2000 Feb; 84(2):158-66. PubMed ID: 10657717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietic inhibitors in uremic serum.
    Freedman MH; Grunberger T; Saunders EF
    Clin Invest Med; 1982; 5(4):237-40. PubMed ID: 7160111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial cell growth inhibitor of normal and pathologic human vitreous.
    Jacobson B; Basu PK; Hasany SM
    Arch Ophthalmol; 1984 Oct; 102(10):1543-5. PubMed ID: 6487121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral inhibitors of the immune response in uremia. II. Further characterization of an immunosuppressive factor in uremic serum.
    Raskova J; Morrison AB; Shea SM; Raska K
    Am J Pathol; 1979 Nov; 97(2):277-90. PubMed ID: 230740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vanadate stimulates bone cell proliferation and bone collagen synthesis in vitro.
    Lau KH; Tanimoto H; Baylink DJ
    Endocrinology; 1988 Dec; 123(6):2858-67. PubMed ID: 3058461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shared pathways of osteoblast mitogenesis induced by amylin, adrenomedullin, and IGF-1.
    Cornish J; Grey A; Callon KE; Naot D; Hill BL; Lin CQ; Balchin LM; Reid IR
    Biochem Biophys Res Commun; 2004 May; 318(1):240-6. PubMed ID: 15110779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells.
    Andress DL; Loop SM; Zapf J; Kiefer MC
    Biochem Biophys Res Commun; 1993 Aug; 195(1):25-30. PubMed ID: 7689835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecular mass inhibitor of growth of MDCK cells derived from pig spinal cord.
    Emoto Y; Kawahara E; Koga Y; Ito T; Tawada K
    J Cell Physiol; 2001 Mar; 186(3):350-6. PubMed ID: 11169973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of uremic "middle molecular" fractions by gas chromatography, mass spectrometry, isotachophoresis, and liquid chromatography.
    Schoots AC; Mikkers FE; Claessens HA; De Smet R; Van Landschoot N; Ringoir SM
    Clin Chem; 1982 Jan; 28(1):45-9. PubMed ID: 7055936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibitors in plasma derived human serum.
    Pigott DA; Grimaldi MA; Dell'Aquila ML; Gaffney EV
    In Vitro; 1982 Jul; 18(7):617-25. PubMed ID: 7141445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor binding protein (IGFBP-3), an inhibitor of serum growth factors other than IGF-I and -II.
    Liu L; Delbé J; Blat C; Zapf J; Harel L
    J Cell Physiol; 1992 Oct; 153(1):15-21. PubMed ID: 1381713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of fractions (chalones) obtained from lymphoid organs on lymphocyte proliferation in vitro.
    Hiestand PC; Borel JF; Bauer W; Kis ZL; Magnée C; Stähelin H
    Agents Actions; 1977 Sep; 7(3):327-35. PubMed ID: 145797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Middle molecules in uremic serum, urine and dialysis fluid.
    Migone L; Dall'taglio P; Buzio C
    Clin Nephrol; 1975; 3(3):82-93. PubMed ID: 1139803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterisation of a growth factor from porcine bone.
    Mayer H; Kukoschke KG
    Eur J Biochem; 1989 May; 181(2):409-15. PubMed ID: 2540973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cultured neurons release an inhibitor of astroglia proliferation (astrostatine).
    Rogister B; Leprince P; Bonhomme V; Rigo JM; Delree P; Colige A; Moonen G
    J Neurosci Res; 1990 Jan; 25(1):58-70. PubMed ID: 2319623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.